FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W51118423> ?p ?o ?g. }

• W51118423 endingPage "4559" @default.
• W51118423 startingPage "4559" @default.
• W51118423 abstract "To assess whole-body fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in the management of small bowel obstructions (SBOs) secondary to gastric cancer and its role in treatment strategies.The medical records of all of the patients who were admitted for an intestinal obstruction after curative resection for gastric cancer were retrospectively reviewed. PET/CT was performed before a clinical treatment strategy was established for each patient. The patients were divided into 2 groups: patients with no evidence of a tumor recurrence and patients with evidence of a tumor recurrence. Tumor recurrences included a local recurrence, peritoneal carcinomatosis or distant metastases. The primary endpoint was the 1-year survival rate, and other variables included patient demographics, the length of hospital stay, complications, and mortality.The median time between a diagnosis of gastric cancer and the detection of a SBO was 1.4 years. Overall, 31 of 65 patients (47.7%) had evidence of a tumor recurrence on the PET/CT scan, which was the only factor that was associated with poor survival. Open and close surgery was the main type of surgical procedure reported for the patients with tumor recurrences. R0 resections were performed in 2 patients, including 1 who underwent combined adjacent organ resection. In the group with no evidence of a tumor recurrence on PET/CT, bowel resections were performed in 7 patients, adhesiolysis was performed in 7 patients, and a bypass was performed in 1 patient. The 1-year survival curves according to PET/CT evidence of a tumor recurrence vs no PET/CT evidence of a tumor recurrence were significantly different, and the 1-year survival rates were 8.8% vs 93.5%, respectively. There were no significant differences (P = 0.71) in the 1-year survival rates based on surgical vs nonsurgical management (0% with nonoperative treatment vs 20% after exploratory laparotomy).(18)F-FDG PET/CT can be used to identify the causes of bowel obstructions in patients with a history of gastric cancer, and this method is useful for planning the surgical management of these patients." @default.
• W51118423 created "2016-06-24" @default.
• W51118423 creator A5004367491 @default.
• W51118423 creator A5021541475 @default.
• W51118423 creator A5033561957 @default.
• W51118423 creator A5041381816 @default.
• W51118423 creator A5054773427 @default.
• W51118423 creator A5063730581 @default.
• W51118423 creator A5071543146 @default.
• W51118423 creator A5074862307 @default.
• W51118423 creator A5080765126 @default.
• W51118423 creator A5083018515 @default.
• W51118423 creator A5083193936 @default.
• W51118423 creator A5087546149 @default.
• W51118423 creator A5091078250 @default.
• W51118423 date "2013-01-01" @default.
• W51118423 modified "2023-10-16" @default.
• W51118423 title "Surgical management of patients with bowel obstructions secondary to gastric cancer" @default.
• W51118423 cites W1849723296 @default.
• W51118423 cites W1964247719 @default.
• W51118423 cites W1968504831 @default.
• W51118423 cites W1969416219 @default.
• W51118423 cites W1970875645 @default.
• W51118423 cites W1990384442 @default.
• W51118423 cites W1996115573 @default.
• W51118423 cites W2000231546 @default.
• W51118423 cites W2005958581 @default.
• W51118423 cites W2011043858 @default.
• W51118423 cites W2038147713 @default.
• W51118423 cites W2038965352 @default.
• W51118423 cites W2042169530 @default.
• W51118423 cites W2042522459 @default.
• W51118423 cites W2043903932 @default.
• W51118423 cites W2045523931 @default.
• W51118423 cites W2058351192 @default.
• W51118423 cites W2075842341 @default.
• W51118423 cites W2080663919 @default.
• W51118423 cites W2105423180 @default.
• W51118423 cites W2118718612 @default.
• W51118423 cites W2166595800 @default.
• W51118423 cites W2246964667 @default.
• W51118423 cites W2321559583 @default.
• W51118423 cites W3148681929 @default.
• W51118423 cites W88019568 @default.
• W51118423 doi "https://doi.org/10.3748/wjg.v19.i28.4559" @default.
• W51118423 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3725382" @default.
• W51118423 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23901233" @default.
• W51118423 hasPublicationYear "2013" @default.
• W51118423 type Work @default.
• W51118423 sameAs 51118423 @default.
• W51118423 citedByCount "3" @default.
• W51118423 countsByYear W511184232015 @default.
• W51118423 countsByYear W511184232021 @default.
• W51118423 countsByYear W511184232023 @default.
• W51118423 crossrefType "journal-article" @default.
• W51118423 hasAuthorship W51118423A5004367491 @default.
• W51118423 hasAuthorship W51118423A5021541475 @default.
• W51118423 hasAuthorship W51118423A5033561957 @default.
• W51118423 hasAuthorship W51118423A5041381816 @default.
• W51118423 hasAuthorship W51118423A5054773427 @default.
• W51118423 hasAuthorship W51118423A5063730581 @default.
• W51118423 hasAuthorship W51118423A5071543146 @default.
• W51118423 hasAuthorship W51118423A5074862307 @default.
• W51118423 hasAuthorship W51118423A5080765126 @default.
• W51118423 hasAuthorship W51118423A5083018515 @default.
• W51118423 hasAuthorship W51118423A5083193936 @default.
• W51118423 hasAuthorship W51118423A5087546149 @default.
• W51118423 hasAuthorship W51118423A5091078250 @default.
• W51118423 hasBestOaLocation W511184232 @default.
• W51118423 hasConcept C121608353 @default.
• W51118423 hasConcept C126322002 @default.
• W51118423 hasConcept C126838900 @default.
• W51118423 hasConcept C141071460 @default.
• W51118423 hasConcept C167135981 @default.
• W51118423 hasConcept C168563851 @default.
• W51118423 hasConcept C195910791 @default.
• W51118423 hasConcept C203092338 @default.
• W51118423 hasConcept C2775842073 @default.
• W51118423 hasConcept C2779013556 @default.
• W51118423 hasConcept C2780283643 @default.
• W51118423 hasConcept C526805850 @default.
• W51118423 hasConcept C71924100 @default.
• W51118423 hasConceptScore W51118423C121608353 @default.
• W51118423 hasConceptScore W51118423C126322002 @default.
• W51118423 hasConceptScore W51118423C126838900 @default.
• W51118423 hasConceptScore W51118423C141071460 @default.
• W51118423 hasConceptScore W51118423C167135981 @default.
• W51118423 hasConceptScore W51118423C168563851 @default.
• W51118423 hasConceptScore W51118423C195910791 @default.
• W51118423 hasConceptScore W51118423C203092338 @default.
• W51118423 hasConceptScore W51118423C2775842073 @default.
• W51118423 hasConceptScore W51118423C2779013556 @default.
• W51118423 hasConceptScore W51118423C2780283643 @default.
• W51118423 hasConceptScore W51118423C526805850 @default.
• W51118423 hasConceptScore W51118423C71924100 @default.
• W51118423 hasIssue "28" @default.
• W51118423 hasLocation W511184231 @default.
• W51118423 hasLocation W511184232 @default.

• next